← Back to headlines
India Investigates Substandard Batch of Abhayrab Rabies Vaccine
Indian regulatory authorities have identified a batch of the Abhayrab rabies vaccine as substandard and initiated an investigation to determine if the product is counterfeit. Health officials are reviewing distribution records and safety protocols following the discovery.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
